S. Ganesh

发表

Plasma protein adsorption and biological identity of systemically administered nanoparticles.

Dongyu Chen, Mansoor Amiji, M. Amiji, 2017, Nanomedicine.

Non-condensing polymeric nanoparticles for targeted gene and siRNA delivery.

Jing Xu, Mansoor Amiji, J. Xu, 2012, International journal of pharmaceutics.

Multi-modal strategies for overcoming tumor drug resistance: hypoxia, the Warburg effect, stem cells, and multifunctional nanotechnology.

Z. Duan, M. Amiji, S. Ganesh, 2011, Journal of controlled release : official journal of the Controlled Release Society.

Antitumor efficacy and tumor-selective replication with a single intravenous injection of OAS403, an oncolytic adenovirus dependent on two prevalent alterations in human cancer

Ying Huang, P. Ryan, J. Jakubczak, 2004, Cancer Gene Therapy.

Hyaluronic acid based self-assembled multifunctional nanosystems to overcome drug resistance in lung cancer

S. Ganesh, 2012 .

Targeting β‐catenin in hepatocellular cancers induced by coexpression of mutant β‐catenin and K‐Ras in mice

Xin Chen, J. Tao, Sucha Singh, 2017, Hepatology.

CG0070, a Conditionally Replicating Granulocyte Macrophage Colony-Stimulating Factor–Armed Oncolytic Adenovirus for the Treatment of Bladder Cancer

D. Ennist, Y. Ge, S. Ganesh, 2006, Clinical Cancer Research.

Protein Corona-Enabled Systemic Delivery and Targeting of Nanoparticles

M. Amiji, Dongyu Chen, S. Ganesh, 2020, The AAPS Journal.

Prolongs Survival of Tumor-Bearing Mice Relaxin-Expressing , Fiber Chimeric Oncolytic Adenovirus

C. Yun, K. Jooss, S. Ganesh, 2007 .

Sustained human factor VIII expression in hemophilia A mice following systemic delivery of a gutless adenoviral vector.

D. Kayda, K. Sakhuja, M. Kaleko, 2002, Molecular therapy : the journal of the American Society of Gene Therapy.

Optimization of the generation and propagation of gutless adenoviral vectors.

D. Kayda, K. Sakhuja, M. Kaleko, 2003, Human gene therapy.

Nano-Platforms for Tumor-Targeted Delivery of Nucleic Acid Therapies

M. Amiji, S. Ganesh, A. Iyer, 2014 .

Seneca Valley Virus, a Systemically Deliverable Oncolytic Picornavirus, and the Treatment of Neuroendocrine Cancers

C. Rudin, D. N. Watkins, K. Burroughs, 2007, Journal of the National Cancer Institute.

The role of surface chemistry in serum protein corona-mediated cellular delivery and gene silencing with lipid nanoparticles.

M. Amiji, Dongyu Chen, S. Ganesh, 2019, Nanoscale.

Development of adenovirus serotype 35 as a gene transfer vector.

M. Kaleko, S. Connelly, S. Ganesh, 2003, Virology.

Multifunctional Polymeric Nanosystems for RNA Interference Therapy

Qiong L. Zhou, M. Amiji, S. Ganesh, 2013 .

Direct Inhibition of β-catenin: A new strategy for colorectal cancer

S. Ganesh, M. Abrams, B. Brown, 2018, Oncoscience.

The role of apolipoprotein- and vitronectin-enriched protein corona on lipid nanoparticles for in vivo targeted delivery and transfection of oligonucleotides in murine tumor models.

Mansoor Amiji, M. Amiji, Dongyu Chen, 2019, Nanoscale.

Hyaluronic acid based self-assembling nanosystems for CD44 target mediated siRNA delivery to solid tumors.

Arun K Iyer, Mansoor M Amiji, M. Amiji, 2013, Biomaterials.

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

H. Dudek, J. Tao, Dongyu Chen, 2016, Molecular Cancer Therapeutics.

RNAi-Mediated β-Catenin Inhibition Promotes T Cell Infiltration and Antitumor Activity in Combination with Immune Checkpoint Blockade

S. Ganesh, Weimin Wang, M. Abrams, 2018, Molecular therapy : the journal of the American Society of Gene Therapy.

Combination of siRNA-directed Gene Silencing With Cisplatin Reverses Drug Resistance in Human Non-small Cell Lung Cancer

Arun K Iyer, Mansoor M Amiji, J. Weiler, 2013, Molecular therapy. Nucleic acids.

Generation of recombinant adenovirus using the Escherichia coli BJ5183 recombination system.

L. Hawkins, S. Ganesh, N. Idamakanti, 2007, Methods in molecular medicine.

Intratumoral Coadministration of Hyaluronidase Enzyme and Oncolytic Adenoviruses Enhances Virus Potency in Metastatic Tumor Models

M. van Roey, K. Jooss, S. Ganesh, 2008, Clinical Cancer Research.

In vivo ligand-inducible regulation of gene expression in a gutless adenoviral vector system.

D. Kayda, K. Sakhuja, M. Kaleko, 2003, Human gene therapy.

Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.

M. van Roey, K. Jooss, S. Ganesh, 2009, Human gene therapy.

Relaxin-expressing, fiber chimeric oncolytic adenovirus prolongs survival of tumor-bearing mice.

C. Yun, K. Jooss, S. Ganesh, 2007, Cancer research.

Enhanced Gene Transfer and Oncolysis of Head and Neck Cancer and Melanoma Cells by Fiber Chimeric Oncolytic Adenoviruses

S. Ganesh, P. Reddy, De-chao Yu, 2006, Clinical Cancer Research.

In vivo biodistribution of siRNA and cisplatin administered using CD44-targeted hyaluronic acid nanoparticles.

Arun K Iyer, Mansoor M Amiji, M. Amiji, 2013, Journal of controlled release : official journal of the Controlled Release Society.

Complete sequence and organization of the human adenovirus serotype 46 genome.

M. Kaleko, S. Connelly, S. Ganesh, 2006, Virus research.

Intraocular gutless adenoviral‐vectored VEGF stimulates anterior segment but not retinal neovascularization

P. Campochiaro, M. Kaleko, S. Connelly, 2004, Journal of cellular physiology.

β-Catenin mRNA Silencing and MEK Inhibition Display Synergistic Efficacy in Preclinical Tumor Models

H. Dudek, S. Ganesh, Weimin Wang, 2017, Molecular Cancer Therapeutics.

Combination therapy with radiation or cisplatin enhances the potency of Ad5/35 chimeric oncolytic adenovirus in a preclinical model of head and neck cancer

Y. Ge, K. Jooss, S. Ganesh, 2009, Cancer Gene Therapy.

Role of vitronectin-rich protein corona on tumor-specific siRNA delivery and transfection with lipid nanoparticles.

A. Lupieri, M. Amiji, Dongyu Chen, 2021, Nanomedicine.

Direct Pharmacological Inhibition of β-Catenin by RNA Interference in Tumors of Diverse Origin

H. Dudek, J. Tao, Dongyu Chen, 2016, Molecular Cancer Therapeutics.